Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Neuroinflammation is Scopus-indexed (Q1, CiteScore 18.3), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1742-2094Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology | 3 / 201 | 98th | Q1 |
| Cellular and Molecular Neuroscience | 5 / 102 | 95th | Q1 |
| Neuroscience (all) | 6 / 112 | 95th | Q1 |
| Immunology | 18 / 243 | 92nd | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 18.3.
Journal of Neuroinflammation is Q1 in Neurology (rank 3 of 201), Q1 in Cellular and Molecular Neuroscience (rank 5 of 102) and Q1 in Neuroscience (all) (rank 6 of 112), by CiteScore 2025. It is ranked in 4 subject areas in all.
Journal of Neuroinflammation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 18.3, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.685, quartile Q1, with an H-index of 189.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$4,090 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Neuroinflammation is published by BioMed Central Ltd. Its ISSN is 1742-2094.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Neuroinflammation has an h-index of 220 and a 2-year mean of 10.52 citations per paper (OpenAlex). Its Scopus CiteScore is 18.3, quartile Q1. On 2-year citations it ranks #3 of 201 Scopus journals in Neurology.
Journal of Neuroinflammation published 342 papers in 2025; its busiest recent year was 2020 with 373. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (48.5%), United States (22.7%) and Germany (4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 24 retracted papers are recorded (4.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.